BamSEC and AlphaSense Join Forces
Learn More

Fennec Pharmaceuticals Inc. – Transcripts

NASDAQ: FENC    
Share price (3/24/26): $6.02    
Market cap (3/24/26): $169 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 03/24/26 Fennec Pharmaceuticals Inc., Q4 2025 Earnings Call, Mar 24, 2026 03/24/26
CY 2025
Earnings Revised 08/14/25 Fennec Pharmaceuticals Inc., Q2 2025 Earnings Call, Aug 14, 2025 08/14/25 Earnings Revised 05/13/25 Fennec Pharmaceuticals Inc., Q1 2025 Earnings Call, May 13, 2025 05/13/25 Earnings Revised 03/10/25 Fennec Pharmaceuticals Inc., Q4 2024 Earnings Call, Mar 10, 2025 03/10/25
CY 2024
Other Revised 12/16/24 Fennec Pharmaceuticals Inc. - Special Call 12/16/24 Earnings Revised 01/03/25 Fennec Pharmaceuticals Inc., Q3 2024 Earnings Call, Nov 07, 2024 11/07/24 Earnings Revised 08/13/24 Fennec Pharmaceuticals Inc., Q2 2024 Earnings Call, Aug 13, 2024 08/13/24 Earnings Revised 05/14/24 Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 05/14/24 Earnings Revised 05/28/24 Fennec Pharmaceuticals Inc., 2023 Earnings Call, Mar 21, 2024 03/21/24
CY 2023
Earnings Revised 11/06/23 Fennec Pharmaceuticals Inc., Q3 2023 Earnings Call, Nov 06, 2023 11/06/23 Earnings Revised 09/04/23 Fennec Pharmaceuticals Inc., Q2 2023 Earnings Call, Aug 03, 2023 08/03/23 Earnings Revised 05/11/23 Fennec Pharmaceuticals Inc., Q1 2023 Earnings Call, May 11, 2023 05/11/23
CY 2020
Other Revised 08/11/20 Fennec Pharmaceuticals Inc. - Special Call 08/11/20 Other Revised 06/22/20 Fennec Pharmaceuticals Inc. - Shareholder/Analyst Call 06/22/20